IRIS is a medium-throughput genomics platform based on microarray technology which allows the molecular diagnostic of hereditary diseases, infectious diseases and pharmacogenomics of drugs
In emerging countries, the access to molecular diagnostic is limited because the most of available technology have been developed in accordance with the characteristics of healthcare systems in advanced countries, which implies certain difficulties for laboratories:
High level of investment in equipment
Expensive consumables
Lack of local technical assistance
High number of samples for each use of the equipment
Demanding requirements of facilities
Requirements of highly qualified personnel
The IRIS Platform has been designed in accordance with the characteristics of healthcare systems in emerging countries, presenting several advantages that, in general, simplify the implementation and make it adaptable to any laboratory:
Modular equipment and low investment
Consumables at lower cost
Scalable
Low number of samples for each use of the equipment
Versatile, many trials can be realized at once
Adaptable fácilmente al workflow de cualquier laboratorio
Easily adaptable to the workflow of any laboratory
Safe and reliable results
Duration times of each stage of the molecular diagnostic process using the IRIS Platform,
DNA Sample + Reagents A
PCR product + Reagents G
PCR product + Reagents H
Microarray + Washing solutions
IRIS software image analysis